>>"pharma execs, reporters, bio-pharma investor"
I highly doubt those people are that well informed that p53 rolls off their lips.
Also, I have to comment on all this ASCO talk. Don't turn it into another binary event. We have no idea what data will be available, what data will be reported at the event, or what results will be made available to the general public, before, during, or after the presentation. All this talk is setting up an expectation for the report that may not be reality yet. If things run smoothly, cohort 4 may have completed by the end of June but no data yet available.
"It ain't what they call you, it's what
you answer to." --WC Fields
